BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, BPC 157: The peptide with big claims and scant evidence STAT Public advisory Think twice before injecting peptides bought online: unauthorized products can seriously harm you